A total of 729 probe sets on the U133 plus 2.0 Affymetrix GeneChip showed foldchange differences above the 1.5 threshold using the Robust Multichip Average intensities. This corresponds to 231 unique genes that were upregulated and 215 unique genes that were down-regulated following 1␣,25(OH)2D3 stimulation. A high similarity between microarray and real-time PCR results was observed for 13 random genes, with a concordance correlation coefficient of 0.91. Real-time PCR was also performed to confirm the regulation of asthma candidate genes. To identify the biological relevance of this regulation, biological pathways analyses were performed. The most significant network of upregulated genes included genes involved in morphogenesis, cell growth, and survival as well as genes encoding structural proteins, which are potentially involved in airway remodeling.
THE VITAMIN D RECEPTOR (VDR) is a ligand-regulated transcription factor that mediates the effects of the biologically active form of vitamin D {1␣,25-dihydroxyvitamin D 3 [1␣,25(OH) 2 D 3 ]}. Upon activation, VDR ligand/receptor complex alters the transcription rate of target genes involved in a wide spectrum of biological responses. Recently, two groups co-reported that genetic variants within the VDR gene were associated with asthma (20, 23) . The mechanisms explaining this association are unclear, but allele-specific expression at this locus implicates the presence of genetic variants that affect VDR expression (19) . The hypothesis that VDR levels play a role in asthma was also reinforced by the resistance of VDR knockout mice to experimentally induced asthma (28) . Indeed, these mice fail to develop airway inflammation, eosinophilia, or airway hyperresponsiveness, despite high IgE concentrations and elevated Th2 cytokines. Many mechanisms have been postulated to explain the link between VDR and asthma. In fact, the potential scenarios are numerous, considering the large number of genes regulated by 1␣,25(OH) 2 D 3 (27) . In addition to having a role in calcium homeostasis and bone metabolism, VDR is also considered an autocrine/paracrine system involved in many physiological and cellular processes including immunoregulation as well as cell proliferation and differentiation (6) .
Bronchial smooth muscle cells (BSMCs) play a crucial role in the pathogenesis of asthma. Indeed, remodeling and abnormal contractility of BSMCs are two major characteristics of asthma. Asthmatic patients have an increase in BSMC mass, which is believed to explain the majority of airway luminal narrowing. This increase in airway smooth muscle content is not fully elucidated but appears to be due to an increase in both myocyte size and number (9) . The accumulation of BSMCs can occur through increased proliferation (increased rate of division), reduced rate of apoptosis or excessive growth and migration of existing smooth muscle populations or subpopulations. Asthmatic patients are also characterized by exaggerated airway narrowing to bronchoconstrictor agonists and attenuated ␤-adrenoceptor-mediated airway relaxation. The BSMCs are recognized to have a central role in the pathological process (7) . Indeed, it was shown that BSMCs constitute an autocrine system that when activated in a sensitized state, is capable of producing and responding to cytokines and other proinflammatory molecules.
Considering the prominent role of BSMCs in the pathogenesis of asthma (12) , we used an in vitro model of human primary BSMCs to investigate gene expression following 1␣,25(OH) 2 D 3 stimulation. Analyses allowed us to elucidate key pathways affected by 1␣,25(OH) 2 D 3 and gain insight on one of many processes that may shed light on the genetic association observed between VDR genetic variants and asthma.
tures were done when cells were at 70 -90% confluence, and harvesting for downstream applications was performed when cells were at near-confluence. All experiments were performed at the 4th passage, and all incubation steps were performed in an atmosphere of 5% CO 2 at 37°C.
1␣,25(OH) 2D3 stimulation. BSMCs were grown in 25-cm 2 flasks in SmGM and starved for 24 h (SmBM supplemented with 0.1% FBS) before stimulation. Supernatant was removed, and cells were incubated for 24 h in fresh growth factor-free medium with 100 nM of 1␣,25(OH) 2D3; (Sigma, St. Louis, MO) or with the same concentration of vehicle (ethanol at 0.05%). The experiment was done in triplicate.
Protein extraction. Medium was removed, and cells were rinsed with HEPES-buffered salt solution (Cambrex). Cells were then lysed with CellLytic MT reagent (Sigma) supplemented by a protease inhibitor cocktail. Cells were incubated on a shaker for 10 min and scraped before collection. Lysed cells were centrifuged to pellet the cellular debris and supernatant was transferred to fresh tubes. Lysates were frozen at Ϫ80°C until utilization.
RNA extraction. Cells were lysed by adding 2 ml of TRIzol reagent (Invitrogen) and homogenized by passing through a syringe with a needle (26G). RNA was picked up in the aqueous phase following phase separation by chloroform. The RNA was then precipitated with isopropanol, washed with ethanol (75%), dissolved in DEPC-treated RNase/DNase-free water, and quantified by spectrophotometry (Ultrospec 2100 pro).
RT-PCR. Two micrograms of RNA were converted to cDNA in a total volume reaction of 20 l using the Oligo(dT) [12] [13] [14] [15] [16] [17] [18] Primer (Invitrogen) and the SuperScript II Reverse Transcriptase enzyme (Invitrogen). PCR was performed in a final volume of 25 l containing 1 l of RT reaction product (17) . The PCR reaction was carried out on a thermocycler (MJ Research PTC 100) and following a 3-min denaturation step at 94°C, 40 PCR amplification cycles were performed as follows: 30 s denaturation at 94°C, 30 s annealing at 58°C, and 45 s extension at 68°C. The cycling was terminated with a 3-min extension at 68°C. VDR was amplified with the sense primer 5Ј-CTGACCCTGGAGACTTTGA-3Ј and the antisense primer 5Ј-TTC-CTCTGCACTTCCTCATC-3Ј. The final reaction volume included 0.04 U/l of Taq DNA polymerase (Invitrogen), 1ϫ PCR buffer, 1.5 mM MgCl2, 0.2 mM of each dNTP, and 0.4 M of each primers.
Western blot. The samples were separated by 10% SDS-PAGE and blotted to polyvinylidene difluoride membrane. The blot was blocked overnight at 4°C in Tris-buffered saline (TBS) containing 5% nonfat milk and 0.05% Tween 20. The VDR Ab-1 rat monoclonal antibody (Clone 9A7y.E10.E4, purified Ab without BSA and Azide; Lab Vision, Fremont, CA) was then added at 1 g/ml (1:200) in the same buffer for 2 h at room temperature. The blot was then washed three times in TBS containing 0.05% Tween 20 and incubated in the same buffer with the peroxidase-conjugated AffiniPure donkey anti-rat IgG (Jackson ImmunoResearch Laboratories, West Grove, PA) for 1 h at 0.16 g/ml (1:5,000). The blot underwent three washing steps and was revealed with the Syngene Image Analysis system after adding the SuperSignal West Femto Maximum Sensitivity Substrate (Pierce, Rockford, IL).
Real-time PCR. The stimulatory action of 1␣,25(OH)2D3 in BSMC was verified by quantifying the relative expression of CYP24A1 by real-time PCR (LightCycler, Roche) using the ribosomal RPS9 gene as housekeeping gene. A total reaction volume of 20 l was inserted in LightCycler capillaries (Roche) containing 2 l of LightCycler FastStart DNA Master SYBR Green I (Roche Applied Science), 3 mM of MgCl2, and 0.4 M of each primer. Cycling conditions for CYP24A1 include a 10-min denaturing step at 95°C and 40 cycles performed as follows: 0 s denaturation at 95°C, 10 s annealing at 60°C, and 8 s extension at 72°C. Data acquisition was performed at the end of the extension. Cycling conditions for RPS9 include a 10-min denaturing step at 95°C and 40 cycles performed as follows: 0 s denaturation at 95°C, 10 s annealing at 55°C, and 10 s extension at 72°C. Data acquisition was performed at 87°C during the increment phase between the extension and the denaturation. The concentrations of the target (CYP24A1) and nonregulated reference (RPS9) genes were calculated from standard curves. The standard curves were generated from three parallel dilution series (1E6 to 1E2) of the CYP24A1 and RPS9 isolated amplicons. One calibrator concentration (1E3) used to construct the standard curve was added to each run to obtain the calibrator-normalized target/reference ratio, which adjusted for sample heterogeneity as well as possible differences in sensitivity between the analyzed samples and those used to construct the standard curve. This ratio was also adjusted for PCR efficiency between the target and the reference by a method implemented in the Relative Quantification Software version 1.0 (Roche). This calibrator-normalized target/reference ratio with efficiency correction was then compared between cells treated or not with 1␣,25(OH)2D3.
Real-time PCR was performed on the ABI Prism 7900HT (Applied Biosystems). The total volume reaction was 10 l containing 5 l of SYBR Green PCR Master Mix (Applied Biosystems), 0.3 M of each primer and 5 ng of cDNA. Cycling conditions were as follows: 2 min of activation at 50°C, 10 min denaturation at 95°C, and 40 amplification cycles consisting of 15 s at 95°C and 1 min at 58°C. Each pair of primers was tested on agarose gel electrophoresis to verify the presence of a single band of the predicted size. Primers used are showed in Table 1 . A total of 96 real-time PCR reactions were performed for each gene. These consist of six replicates of the following: a calibration curve from a twofold dilution series ranging from 20 to 0.078 ng of nonstimulated BSMC cDNA (9 dilutions), a control containing no cDNA, and each of the six experimental samples. The quantification for a given gene was always run in the same plate. However, the location of the nine dilutions for the standard curve, the six experimental samples, and the control were randomized within the 384-well plates. Results of the experimental samples were calibrated according to the standard curve. The average of replicates for each sample was obtained and normalized to the GAPDH average to obtain the target/ reference ratio. This ratio was then average from the control (n ϭ 3) and the 1␣,25(OH)2D3-treated (n ϭ 3) samples. Finally, fold-changes in gene expression levels were obtained by dividing the control average ratio from the 1␣,25(OH)2D3 average ratio.
Microarray. Expression studies were performed using the human U133 plus 2.0 Affymetrix GeneChip microarrays (Affymetrix). RNA was reverse transcribed into cDNA and in vitro transcription was performed to generate biotin-labeled cRNA for subsequent hybridization. Hybridized target cRNA was then stained with streptavidin phycoerythrin, and arrays were scanned using a GeneArray Scanner at an excitation wavelength of 488 nm. Expression values were extracted using the robust multichip average (RMA) method (11) . The complete data set has been deposited in the National Center for Biotechnology Information's Gene Expression Omnibus (GEO, http://www.ncbi. nlm.nih.gov/geo/) repository and are accessible through GEO Series accession number GSE5145. An RMA threshold of 1.5 was used as a threshold to claim significant regulation. This corresponds to a false discovery rate of 2.75% based on the significance analysis of microarrays method (26) .
Biological pathway analyses. The Gene Map Annotator and Pathway Profiler (3, 5) (GenMAPP, www.genmapp.org) and the Ingenuity Pathway Analysis system (Ingenuity Systems, www.ingenuity.com) were used to visualize gene expression data in the context of biological pathways. In both bioinformatics tools, an RMA threshold of 1.5 was used to identify up-or downregulated genes. In GenMAPP, three color-coding criteria were used. The first two conditions tested pathways (MAPPs) with up-and downregulated genes, respectively. The third condition was set to identify pathways having both up-and downregulated genes. The GenMAPP input file as well as the MAPPFinder results can be found in the supplementary materials (http:// www.genomequebec.mcgill.ca/downloads/other/supplMaterials.zip). Similarly, three rounds of analyses were performed with the Ingenuity Pathway Analysis system considering 1) upregulated genes, 2) downregulated genes, and 3) both up-and downregulated genes. The Ingenuity input file and the top results including networks and canonical pathways can be found in the supplementary materials.
RESULTS

VDR is functional in BSMCs.
RT-PCR and Western blot were conducted to demonstrate the presence of VDR at the mRNA transcript and protein levels in BSMCs (data not shown). The functionality of the receptor was evaluated using 1␣,25(OH) 2 D 3 stimulation. In many cell types, the CYP24A1 gene is known to be one of the most upregulated genes following 1␣,25(OH) 2 D 3 stimulation (21). The relative expression of CYP24A1 was thus tested in the BSMC model by real-time using ribosomal RPS9 gene as a housekeeping gene. After 24 h of BSMC stimulation with 100 nM of 1␣,25(OH) 2 D 3 , the CYP24A1 mRNA transcript increased by a factor of 241 (Fig. 1) . With the same stimulation, the VDR mRNA transcript increased by 1.6-fold (Fig. 1) Figure 2 shows a heat map illustrating the within-group variance for the 231 genes upregulated and the 215 genes downregulated.
Global validation of microarray. Recently, Miron et al. (18) developed a methodology for validating microarray data. The method consists of validating a subset of randomly selected genes by real-time PCR and extrapolation to the remaining nonvalidated genes. More specifically, the 231 upregulated genes in the experiment were sorted by descending order of fold-change. Gene selection was then performed by a randomstratified sampling method using a bin size of 16 (by randomly selecting one gene per bin). As a result, the following 14 genes 
F, forward; R, reverse. Genes are official Entrez Gene symbols. were selected and tested by real-time PCR: DKK2, CRIP1, DRCTNNB1A, BTC, TPARL, ZNF533, ATP8A1, CXCL12, USP13, MAN1A1, CL640, ZNF326, RBJ, and TMOD1. The ZNF533 gene was excluded from the subsequent analyses because the standard curve was unreliable. A concordant correlation coefficient (CCC) was then estimated to evaluate the similarity between microarray and real-time PCR results. The CCC is a global quality index combining the accuracy and precision coefficients in one index (18) . As shown in Fig. 3 , a CCC value of 0.91 was observed for the present experiment, which indicates very good agreement between microarray and real-time PCR results. This result can be visualized by how close the data points are from the regression line (correlation ϭ 0.93) and how close the regression line is from the identity line.
Validation of candidate genes. A total of 15 additional genes were assessed by real-time PCR (Fig. 4) . Three were selected to confirm well know genes regulated by 1␣,25(OH) 2 D 3 including VDR itself, CYP24A1 and thrombomodulin (THBD). The highest up-and downregulated genes were also included (SULT1C1 and DHRS3, respectively). Ten other genes showing regulation with microarrays were evaluated by real-time PCR based on their potential effect in the pathogenesis of asthma. In all cases, the direction of change was similar between microarray and real-time PCR. In addition, the foldchanges observed between the two techniques were similar except for two highly upregulated genes. Microarray foldchanges for CYP24A1 and SULT1C1 were 3.8 and 11.8, respectively, and the same values for real-time PCR were 308.6 and 35.9.
Pathway analyses. GenMAPP and MAPPFinder were used to identify pathways having a significant proportion of up-and down-regulated genes. Pathways were derived from two sources: local MAPPs and Gene Ontology (GO) terms. A total of 97 and 366 genes regulated in the experiment were present in local MAPPs and GO terms, respectively. For each source, three runs of analyses were performed to identify 1) pathways with upregulated genes, 2) pathways with downregulated genes, and 3) pathways having both up-and downregulated genes. All pathways reaching a P value below 0.05 for local MAPPs and 0.001 for GO terms were summarized and can be viewed in the supplementary materials. For local MAPPs, four pathways met the significantly increased criterion, four met the significantly decreased criterion and eight met the third criterion for genes up-and downregulated. The same numbers for the GO terms were 10, 9, and 10, respectively. Some of the GO terms are very general including thousands of genes and some have large degree of interrelatedness, but all have been retained for completeness. The relevance of these pathways is considered in the DISCUSSION.
The Ingenuity Pathway Analysis system was also used to analyze the same expression dataset in the context of biological pathways. A total of 259 genes were eligible for generating networks. Again, three runs of analyses were performed considering 1) only upregulated genes, 2) only downregulated genes, and 3) up-and downregulated genes. The top 10 canonical pathways and the top networks generated by the system can be visualized in the supplementary materials. The top functions associated with the most significant network of upregulated genes were cellular movement, cellular growth, and proliferation, and cell death. This particular network is shown in Fig. 5 , and its relevance is considered in DISCUSSION. The top functions associated with the most significant network of downregulated genes were gene expression, cancer, and cell death. Finally, the top functions associated with the most Table S1. significant network of up-and downregulated genes were cellular growth and proliferation, cancer, and cellular movement.
DISCUSSION
Recent genetic association studies have implicated VDR genetic variants in the etiology of asthma (20, 23, 29) . However, the mechanistic understanding of this relationship is unclear. To unravel this issue, we explored gene expression in BSMC following 1␣,25(OH) 2 D 3 stimulation. The first set of experiments demonstrated that VDR is present and functional in BSMC. Microarray data demonstrated that 1␣,25(OH) 2 D 3 regulates a large number of genes in these cells, which is concordant to observations made with other cell lines (27) . The microarray data were then validated by a method recently described (18) , which confirmed the reliability of the data. A number of candidate genes were also validated and showed great concordance between microarray and real-time PCR results. Finally, bioinformatics tools were used to expose the biological relevance of this process. Based on the analyses, many biological scenarios can be conceived, but the most affected networks of genes suggest functions related to cell movement, growth and survival that are potentially important for airway remodeling.
A quick glance at the top genes regulated by 1␣,25(OH) 2 D 3 and the GenMAPP/MAPPFinder results reveals many genes implicated in asthma, either by genetic association methods or functional studies. First, an important transcription factor (CEBPB) as well as a proinflammatory cytokine (IL6) involved in immune and inflammatory responses were upregulated following 1␣,25(OH) 2 D 3 stimulation. Second, 1␣,25(OH) 2 D 3 also increased the expression of AKR1C3, which is believed to play an important role in the pathogenesis of allergic diseases by regulating the synthesis of prostaglandins (PG), such as PGD2. Indeed, the enzyme encoded by the AKR1C3 gene catalyzes the reduction of PGD2, PGH2, and phenanthrenequinone, and the oxidation of 9␣,11␤-PGF2 to PGD2. PGD2 is a lipid mediator that is known to direct the earliest phases of T-cell recruitment to the airways immediately after exposure to allergens (16) . Furthermore, the 20-ketosteroid reductase activity of the AKR1C3 enzyme is known to inactivate cortisol (25) , which may promote the inflammatory responses in allergic airways. A third potential scenario implicates genes involved in smooth muscle contraction. Smooth muscle contraction is mediated by Ca 2ϩ -dependent and Ca 2ϩ -independent pathways. The later Ca 2ϩ -independent pathway, termed Ca 2ϩ sensitization, is mainly regulated by a monomeric GTP binding protein RhoA and its downstream target Rho-kinase (2). A small Rho GTPase transcript (CDC42EP3) was highly upregulated following 1␣,25(OH) 2 D 3 treatment. It is tempting to speculate that this upregulation will increase Rho-kinase activity, leading to an inhibition of MLC phosphatase, and cause the promotion of a contractile state, that is Ca 2ϩ sensitization. In addition, 1␣,25(OH) 2 D 3 also upregulated the inositol 1,4,5-triphosphate receptor (ITPR1). Activation of this receptor is known to cause calcium release from the sarcoplasmic reticulum. Together these data suggest that 1␣,25(OH) 2 D 3 treatment in BSMC induces genes in both Ca 2ϩ -dependent and Ca 2ϩ -independent pathways in a manner that could potentially lead to greater bronchial smooth muscle contractility. Finally, activation of glucocorticoids may also be involved. The HSD11B1 gene encodes for the 11␤-hydroxysteroid dehydrogenase type 1 enzyme (11␤-HSD1). 11␤-HSD1 is a bidirectional enzyme but in intact cells displays predominately oxo-reductase activity, a reaction requiring NADPH and leading to activation of glucocorticoids (conversion of inactive cortisone to active cortisol). Thus, there is a close relationship between the 11␤-HSD1 and the NADPH generation system. The pentose phosphate pathway is a major source of NADPH in the cytosol. The rate-limiting enzyme in this system is glucose-6-phosphate dehydrogenase (G6PD). It is possible that G6PD provides NADPH to 11␤-HSD1 (8 Although biologically relevant, these observations are made on the basis of only a few of the many genes regulated by 1␣,25(OH) 2 D 3 . To gain a more comprehensive understanding, the Ingenuity Pathways Analysis system was used to generate a knowledge-based network of regulated genes. This bioinformatics tool reveals networks of genes with important functions related to airway remodeling. The most significant network of upregulated genes contains nodes directly associated with asthma pathogenesis (Fig. 5) . VEGF is a highly connective node in this network and is known to induce remodeling. Indeed, VEGF was shown to cause smooth muscle hyperplasia and subepithelial fibrosis as well as to induce airway hyperresponsiveness in lung-targeted VEGF transgenic mice (15) . The IL6 gene is also highly connected in this network. Overexpression of IL-6 in mice is known to increase the thickness of the bronchial wall and to enhance accumulation of subepithelial and adventitial collagen (14) . However, despite these changes, the IL6-transgenic mice shows decreased methacholine responsiveness (4). In agreement, the IL6-deficient mice exhibited thinner basement membrane and less subepithelial fibrosis with no change in airway responsiveness (22) . Other genes in this network have important implications in airway remodeling. First, fibronectin (FN1), is a major constituent of the extracellular matrix and promotes cytoskeletal organization as well as cell adhesion and migration. FN1 is essential for branching morphogenesis of many organs including the lung (24) . Secondly, the insulin-like growth factor binding protein 3 was shown to inhibit cell growth in lung cancer cell lines and tumorigenicity in xenotransplated mice (10) . Third, the chemokine ligand 12 (CXCL12) transgene, also named SDF-1 (stromal cell-derived cell factor), demonstrates enhanced survival after growth factors withdrawal in myeloid progenitor cell lines (1) . Furthermore, the CXCL12/CXCR4 axis was found to play a pivotal role in vascular remodeling by promoting smooth muscle cell hyperplasia (32) as well as to regulate signaling pathways involved in smooth muscle cell migration (13) . Finally, collagen type 1 alpha 1 (COL1A1) is an important structural protein that was also upregulated in this network. Taken together, the most significant network of upregulated genes included genes involved in remodeling, airway hyperresponsiveness, morphogenesis, cell growth, and cell survival, as well as extracellular matrix.
Extracting biological information from microarray data is a major challenge. Here we used bioinformatics tools containing knowledge-based information to generate new networks and test pre-existing pathways. These tools can facilitate the interpretation of the overwhelming amount of data produced by this technology. However, identification of a functional pathway by these tools does not prove its implication and must be confirmed by other studies. For example, confirming whether asthmatic patients manifest perturbations of the network identified here will be important. It should also be noted that the source of data coming from the mRNA transcript level may not reflect the protein and the cellular functions. Another limitation of the present study comes from using only BSMC to understand the implication of VDR in asthma, which is a disease that involves many cell types.
Many microarray studies were conducted in different cell types to unravel the genes regulated by vitamin D (Supplementary Table S2 ). Numerous features that vary between these studies make comparisons difficult, including cellular origins, species, microarray platforms, statistical methods, thresholds to claim significance, and vitamin D stimulation conditions (concentration and time). In addition, many reports provide only a partial list of modulated genes without access to full data. Recently, Zhang et al. (33) compared vitamin D-regulated genes reported by different researchers using microarray analysis in eight different cancer cell lines. They concluded that only a few genes were commonly identified by two different groups and, except for the enzyme 24-hydroxylase (CYP24A1), which was used to confirm the biologic response of 1␣,25(OH) 2 D 3 in the present study, no other gene was identified by more than three groups. Perhaps the best comparison with our study is the one conducted by Wu-Wong et al. (30) using human coronary artery smooth muscle cells. However, from the 176 genes regulated in their study, they only list 21 genes involved in cell proliferation/differentiation and 16 genes linked to cardiovascular functions. Despite this limiting comparison, five genes were upregulated in both datasets: CYP24A1, MAPK13, TGFB3, THBD, and G0S2.
In conclusion, we have provided the first evidence that VDR is present and functional in BSMC. We also demonstrated that the expression of many genes are regulated in these cells following 1␣,25(OH) 2 D 3 stimulation, including genes previously implicated in asthma predisposition and pathogenesis. Analyses of the expression dataset permit the elaboration of different biological scenarios by which VDR might be associated with asthma, including smooth muscle cell contraction and inflammation as well as glucocorticoid and prostaglandin regulation. More comprehensive analyses indicate a network of upregulated genes with functional importance for cellular movement, cellular growth and proliferation, and cell death. This network of 1␣,25(OH) 2 D 3 -upregulated genes in BSMC may play an important role in airway remodeling, and therefore may have important implication in the pathogenesis of asthma. Further studies are required to test these arguments.
